Mankind Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MANKIND PHARMA, and what generic and branded alternatives to MANKIND PHARMA drugs are available?
MANKIND PHARMA has forty-five approved drugs.
There are three tentative approvals on MANKIND PHARMA drugs.
Summary for Mankind Pharma
| US Patents: | 0 |
| Tradenames: | 40 |
| Ingredients: | 40 |
| NDAs: | 45 |
| Patent Litigation for Mankind Pharma: | See patent lawsuits for Mankind Pharma |
Drugs and US Patents for Mankind Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mankind Pharma | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 215710-005 | Feb 9, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Mankind Pharma | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 214255-002 | Aug 1, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Mankind Pharma | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 217692-003 | Nov 29, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
